Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
How is the Transcatheter Embolization And Occlusion Devices Market size predicted to change over the forecast window of 2026–2035?
The transcatheter embolization and occlusion devices market has expanded significantly in recent years. It is projected to increase from $5.23 billion in 2025 to $5.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.6%. This historical growth can be linked to the rise in interventional radiology procedures, the growing incidence of vascular disorders, the enhanced availability of catheter-based therapies, the increasing embrace of minimally invasive treatments, and advancements in imaging-guided intervention techniques.
The transcatheter embolization and occlusion devices market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a value of $8.33 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. Factors driving this expansion during the projection period include a heightened demand for targeted embolization therapies, the growing acceptance of sophisticated embolic materials, the broadening scope of oncology and neurointerventional procedures, an increasing emphasis on precision medicine, and increased funding for interventional healthcare infrastructure. Key trends expected within this forecast timeframe encompass the wider adoption of minimally invasive embolization techniques, an escalating need for advanced liquid embolic agents, the increasing application of detachable and coated coils, the development of image-guided interventional methodologies, and a stronger emphasis on precision occlusion technologies.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15944&type=smp
Which Drivers Are Contributing To The Expansion Of The Transcatheter Embolization And Occlusion Devices Market?
The increasing demand for minimally invasive surgical techniques is anticipated to fuel the expansion of the transcatheter embolization and occlusion devices market in the future. These surgeries involve using small incisions or robotic-assisted tools to access internal structures while minimizing tissue damage, leading to reduced trauma, shorter recovery times, less postoperative pain, and a lower risk of complications. The rising preference for these procedures is driven by advancements in surgical technology, greater patient awareness of less-invasive options, and improved clinical outcomes. Transcatheter embolization and occlusion devices support such minimally invasive interventions by enabling targeted, catheter-based treatment with high precision and minimal disruption to surrounding tissues. For instance, in January 2025, according to Intuitive Surgical, Inc., a US-based medical technology corporation, full-year 2024 worldwide da Vinci procedures increased by approximately 17% compared with 2023. The company expects worldwide da Vinci procedures to grow by approximately 13% to 16% in 2025 compared with 2024. Therefore, the increasing adoption of minimally invasive techniques is driving the growth of the transcatheter embolization and occlusion devices market.
What Segment Classifications Make Up The Transcatheter Embolization And Occlusion Devices Market?
The transcatheter embolization and occlusion devices market covered in this report is segmented –
1) By Type: Coil, Non-Coil
2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users
Subsegments:
1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil
2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles
Which Trends Are Influencing The Performance And Direction Of The Transcatheter Embolization And Occlusion Devices Market?
Leading companies in the transcatheter embolization and occlusion devices market are concentrating on developing sophisticated solutions, such as liquid embolic systems, to address the increasing demand for less invasive vascular interventions and efficient management of arterial bleeding. A liquid embolic system is characterized as a non-adhesive, polymer-based embolization technology delivered through a microcatheter, which solidifies upon contact with blood, facilitating controlled occlusion of abnormal or damaged vessels with superior penetration and precision compared to conventional coil-based methods. For instance, in July 2025, Medtronic plc., a US-based medical technology company, commenced clinical evaluation of its Onyx Liquid Embolic System (LES) via an IDE study, intended for the embolization of arterial hemorrhage in the peripheral vasculature. This innovative system utilizes an ethylene-vinyl alcohol (EVOH) copolymer dissolved in DMSO and combined with tantalum powder for radiopacity, enabling physicians to visualize and guide its delivery in real time. As the solvent diffuses, a cohesive embolus forms, allowing for targeted vessel occlusion with a reduced likelihood of catheter entrapment and improved safety in complex anatomical settings. Engineered for use in active peripheral arterial bleeding, the system enhances accuracy, supports minimally invasive treatment approaches, and broadens the therapeutic possibilities for interventional specialists.
Which Key Players Are Driving Competition In The Transcatheter Embolization And Occlusion Devices Market?
Major companies operating in the transcatheter embolization and occlusion devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., Boston Scientific Neurovascular
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Transcatheter Embolization And Occlusion Devices Market?
North America was the largest region in the transcatheter embolization and occlusion devices market in 2025. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Transcatheter Embolization And Occlusion Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15944&type=smp
Browse Through More Reports Similar to the Global Transcatheter Embolization And Occlusion Devices Market 2026, By The Business Research Company
Tumor Embolization Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Neurovascular Embolization Devices Global Market Report 2026
Vascular Embolization Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company